Skip to Content

Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in the Securities Class Action Lawsuit against Heron Therapeutics, Inc.

If you purchased Heron Therapeutics, Inc. shares between October 31, 2018 and April 30, 2019, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please complete the following Investor Certification.  [contact-form-7 id=”1183″ title=”Heron Therapeutics, Inc. Investor Certification”]

On June 3, 2019, a class action lawsuit was filed in the United States District Court for the Southern District of California against Heron Therapeutics, Inc. (NASDAQ: HRTX).  Federman & Sherwood reminds current and former shareholders of Heron Therapeutics, Inc. that they only have until Monday, August 5, 2019 to move the court for appointment as a lead plaintiff in this case.  The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:  Robin Hester at

let’s connect

Click Here to Complete Federman & Sherwood Fee Agreement.


10205 North Pennsylvania Avenue
Oklahoma City, Oklahoma 73120

TEXAS Office

212 W. Spring Valley Road,
Richardson, Texas 75081